BGN16.08 -0.3 -1.8%
Last Trade - 07/01/15
| Market Cap | £n/a |
| Enterprise Value | £n/a |
| Revenue | £n/a |
| Position in Universe | th / 646 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Dec | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.12 | 0.13 | 0.18 | 0.10 | 0.001 | 0.000 | -100.0% | ||||
| +207.8 | +33.3 | |||||||||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Bioiasis AD is a Bulgaria-based company that specializes in the wholesale of biomaterial products surgical supplies such as medicines, medical materials and instruments, sanitary and hygienic products, disinfectants, medical cosmetics and appliances, as well as medical equipment and consumables. The Company distributes cardiology products like Paclitaxel Eluting Balloon and Paclitaxel Eluting Stent; orthopedics products like Lineage Acetabular Cups, Advance Medical Pivot Knee and Olympia Total Shoulder System; neurosurgery products like pressure valve, mano-pressure valve, cervical disc, cervical cage and anterior cervical plate; and hemostasis products like haemostatic gauze, haemostatic powder and resorbable collagen hemostat. The Company distributes its products nationally and internationally, in Bulgaria, Greece, Cyprus, Romania, Serbia, the Russian Federation and the United States.
| Last Annual | December 31st, 2020 |
| Last Interim | December 31st, 2020 |
| Incorporated | April 18, 2005 |
| Public Since | May 8, 2008 |
| No. of Shareholders: | n/a |
| No. of Employees: | n/a |
| Sector | Healthcare |
| Industry | Healthcare Equipment & Supplies |
| Index | |
| Exchange | Bulgarian Stock Exchange |
| Shares in Issue | 1,171,215 |
| Free Float | (0.0%) |
| Eligible for |
✓
ISAs
✓
SIPPs
|
| Address | 70 Ralevitsa Str Atelier 1, SOFIA, 1618, Bulgaria |
| Web | http://www.bioiasis.com/ |
| Phone | +359 2 4807788 |
| Contact | () |
| Auditors | ABAGAR AUDIT LTD |
As of 07/01/15, shares in Bioiasis AD are trading at BGN16.08, giving the company a market capitalisation of £n/a. This share price information is delayed by 15 minutes.
Shares in Bioiasis AD are currently trading at BGN16.08 and the price has moved by -18.38% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Bioiasis AD price has moved by -36.75% over the past year.
There are no analysts currently covering Bioiasis AD.
Bioiasis AD is scheduled to issue upcoming financial results on the following dates:
Bioiasis AD does not currently pay a dividend.
Bioiasis AD does not currently pay a dividend.
Bioiasis AD does not currently pay a dividend.
To buy shares in Bioiasis AD you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Bioiasis AD are currently trading at BGN16.08, giving the company a market capitalisation of £n/a.
Here are the trading details for Bioiasis AD:
We were not able to load our ranking data for Bioiasis AD
We were not able to load any forecast data for Bioiasis AD.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Bioiasis AD. Over the past six months, the relative strength of its shares against the market has been -22.73%. At the current price of BGN16.08, shares in Bioiasis AD are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We were not able to find PE ratio data for Bioiasis AD.
Bioiasis AD's management team is headed by:
Here are the top five shareholders of Bioiasis AD based on the size of their shareholding:
